On this page:

The department has an active research program, consisting of investigator-initiated academic studies, academic and commercial clinical trials (phase I-III, observational and therapeutic). This is supported by all consultants as investigators and a regular stream of academic hepatology fellows enrolled for higher research degrees at St George’s University.  Research has focussed on hepatitis B and C, NAFLD/NASH and more recently acute on chronic liver failure (ACLF) and portal hypertension.

We work closely with academic collaborators at SGUL and beyond, the NIHR clinical research network and the pharmaceutical industry to provide clinical trial options for our patients so they may access novel treatment options or strategies. Most of our trials are carried out in the St George’s Clinical Research Facility (https://www.sgul.ac.uk/research/our-research-facilities/clinical-research-facility), which has achieved full accreditation by the National Institute of Health Research (NIHR).

For a list of current open clinical trials see below and click Hepatology: